Innovative Trends in Cardiovascular Medicine and Surgery

A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425). This special issue belongs to the section "Cardiovascular Clinical Research".

Deadline for manuscript submissions: closed (20 April 2024) | Viewed by 849

Special Issue Editors


E-Mail Website
Guest Editor
1. Cardiovascular Service Line, Virtua Health, Marlton, NJ 08053, USA
2. Department of Cardiothoracic Surgery, Virtua Our Lady of Lourdes Hospital, Camden, NJ 08013, USA
Interests: adult cardiovascular surgery; advanced heart failure; heart transplantation; machine learning
Division of Cardiac Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
Interests: aortic stenosis; cardiac surgery; coronary artery bypass graft surgery (CABG); coronary artery disease; transcatheter aortic valve replacement (TAVR); valvular heart surgery

Special Issue Information

Dear Colleagues,

Cardiovascular medicine and surgery remain at the forefront of clinical innovation in the midst of a rapidly evolving field of medicine at large. With the advent of digital technology, the pace at which novel techniques and knowledge are introduced to specialties is increasing exponentially.

In the last several years, there have been many major milestones that have changed the delivery of cardiovascular care to patients, including transcatheter valves or structural heart interventions, non-invasive digital hemodynamic monitors, minimally invasive surgical platforms, and artificial intelligence.

This Special Issue of JCDD will highlight and showcase the latest innovations that are promoting the most advanced iterations of clinical research and experimental concepts in cardiovascular specialties.

Dr. Chun Woo Choi
Dr. Hamza Aziz
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cardiovascular
  • cardiac surgery
  • innovation
  • translational science
  • machine learning
  • artificial intelligence

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

18 pages, 1729 KiB  
Review
Rheumatic and Degenerative Mitral Stenosis: From an Iconic Clinical Case to the Literature Review
by Francesca Napoli, Ciro Vella, Luca Ferri, Marco B. Ancona, Barbara Bellini, Filippo Russo, Eustachio Agricola, Antonio Esposito and Matteo Montorfano
J. Cardiovasc. Dev. Dis. 2024, 11(5), 153; https://doi.org/10.3390/jcdd11050153 - 17 May 2024
Viewed by 449
Abstract
Mitral stenosis (MS) poses significant challenges in diagnosis and management due to its varied etiologies, such as rheumatic mitral stenosis (RMS) and degenerative mitral stenosis (DMS). While rheumatic fever-induced RMS has declined in prevalence, DMS is rising with aging populations and comorbidities. Starting [...] Read more.
Mitral stenosis (MS) poses significant challenges in diagnosis and management due to its varied etiologies, such as rheumatic mitral stenosis (RMS) and degenerative mitral stenosis (DMS). While rheumatic fever-induced RMS has declined in prevalence, DMS is rising with aging populations and comorbidities. Starting from a complex clinical case of DMS, the aim of this paper is to review the literature on mitral stenosis by analyzing the available tools and the differences in terms of diagnosis and treatment for rheumatic and degenerative stenosis. Emerging transcatheter techniques, such as transcatheter mitral valve replacement (TMVR) and lithotripsy-facilitated percutaneous mitral commissurotomy (PMC), represent promising alternatives for DMS patients deemed unfit for surgery. In particular, intravascular lithotripsy (IVL) has shown potential in facilitating percutaneous interventions by fracturing calcific deposits and enabling subsequent interventions. However, larger prospective studies are warranted to validate these findings and establish IVL’s role in DMS management. To further enhance this technique, research could focus on investigating the long-term outcomes and durability of mitral lithotripsy, as well as exploring its potential in combination with PMC or TMVR. Full article
(This article belongs to the Special Issue Innovative Trends in Cardiovascular Medicine and Surgery)
Show Figures

Figure 1

Back to TopTop